Pillstats
Labeler · US market

Lilly del Caribe, Inc.

Lilly del Caribe, Inc. is a US drug labeler with US FDA registrations covering 12 drug concepts (10 currently active) across 48 packages. It is currently the only active US supplier of 5 drugs.

ACTIVE — US
openFDA · updated weekly
Labeler codes0110
Active drugs10
Registrations36 active / 46
Packages48
Sole supplier of5 drugs

Portfolio12 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Duloxetine Hydrochloride
capsule, delayed release
other77SUPPLYING
Orforglipron
capsule
other66SUPPLYING
Orforglipron
tablet, film coated
other66SUPPLYING
Tadalafil
tablet, film coated
other44SUPPLYING
Insulin Lispro
crystal
other24SUPPLYING
Abemaciclib
tablet
other44SUPPLYING
Baricitinib
tablet, film coated
other33SUPPLYING
Lasmiditan
tablet
other22SUPPLYING
Tadalafil
tablet
other11SUPPLYING
Raloxifene Hydrochloride
tablet
other11SUPPLYING
Atomoxetine Hydrochloride
capsule
other77DISCONTINUED
Fluoxetine Hydrochloride
capsule
other33DISCONTINUED